Edition:
United States

Humana Inc (HUM)

HUM on New York Consolidated

213.67USD
21 Apr 2017
Change (% chg)

$-0.57 (-0.27%)
Prev Close
$214.24
Open
$211.50
Day's High
$214.48
Day's Low
$210.01
Volume
2,267,444
Avg. Vol
1,544,455
52-wk High
$220.49
52-wk Low
$150.00

HUM

Chart for HUM

About

Humana Inc. is a health and well-being company. The Company's segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental... (more)

Overall

Beta: 0.88
Market Cap(Mil.): $30,829.27
Shares Outstanding(Mil.): 144.28
Dividend: 0.40
Yield (%): 0.75

Financials

  HUM Industry Sector
P/E (TTM): 52.80 23.40 29.95
EPS (TTM): 4.05 -- --
ROI: -- 0.02 13.21
ROE: 5.84 14.57 14.38

LPC: US healthcare lending rouses from policy-induced sedation

NEW YORK US drug distributor Cardinal Health Inc’s deal to buy Medtronic Plc’s medical supplies units days after Abbott Laboratories agreed to a long-awaited purchase of diagnostic testing company Alere Inc has raised the pulse of a sector suppressed by potential healthcare policy upheaval.

Apr 20 2017

LPC: U.S. healthcare lending rouses from policy-induced sedation

NEW YORK U.S. drug distributor Cardinal Health Inc’s deal to buy Medtronic Plc’s medical supplies units days after Abbott Laboratories agreed to a long-awaited purchase of diagnostic testing company Alere Inc has raised the pulse of a sector suppressed by potential healthcare policy upheaval.

Apr 20 2017

LPC: US healthcare lending rouses from policy-induced sedation

NEW YORK, April 20 US drug distributor Cardinal Health Inc’s deal to buy Medtronic Plc’s medical supplies units days after Abbott Laboratories agreed to a long-awaited purchase of diagnostic testing company Alere Inc has raised the pulse of a sector suppressed by potential healthcare policy upheaval.

Apr 20 2017

BRIEF-Humana board declares payment of qtrly dividend to stockholders

* Humana board declares payment of quarterly dividend to stockholders

Apr 20 2017

BRIEF-Humana reports realignment of financial reporting segments

* Humana-Realigned certain of its businesses for reporting segments; segments include retail,group and specialty,healthcare services,individual commercial Source text for Eikon: Further company coverage:

Apr 17 2017

BRIEF-Vanderbilt Health Affiliated Network, Humana enter value-based agreement

* Vanderbilt Health Affiliated Network, Humana enter value-based agreement to benefit medicare advantage patients

Mar 29 2017

BRIEF-CalPERS requests Humana's shareowners vote "for" proposal requesting proxy access

March 27 California Public Employees’ Retirement System:

Mar 27 2017

BRIEF-Humana completes aggregate $1.0 bln of senior notes offering

* Humana completes aggregate $1.0 billion of senior notes offering Source text for Eikon: Further company coverage:

Mar 16 2017

Fitch Rates Humana's Planned Issuance 'BBB (EXP)'

(The following statement was released by the rating agency) CHICAGO, March 13 (Fitch) Fitch Ratings has assigned a 'BBB(EXP)' rating to Humana Inc.'s (HUM) planned offering of senior unsecured notes, likely in a mix of 10- and 30-year maturities approximating $1 billion. The ratings are equivalent to Fitch's ratings on HUM's outstanding senior unsecured notes. The Outlook on HUM's 'BBB+' Issuer Default Rating (IDR) is Stable. Fitch anticipates HUM using the proceeds from the planned issue

Mar 13 2017

Honda to begin U.S. production of new 10-speed transmission

Honda Motor Co Ltd said on Monday it had invested nearly $150 million in two U.S. plants for making 10-speed automatic transmission for front-wheel-drive vehicles.

Mar 06 2017

More From Around the Web

Earnings vs. Estimates